MyndYou, a Tel Aviv, Israel-based technology company that uses artificial intelligence (AI) to aid clinicians in tracking and addressing cognitive decline among seniors, received an initial seed funding of undisclosed amount.
The round was led by Howard Lee Morgan, American venture capitalist, philanthropist, socialite, angel investor, author and contributing writer for Business Insider, with participation from Musketeer Capital and additional private investors.
The company intends to use the funds to advance collaborations already in place with several US-based partners including Massachusetts General Hospital. In partnership with MyndYou, Mass General recently announced a research trial utilizing the MyndYou Intelligence platform for the remote, automated detection of subtle changes in speech patterns of Alzheimer’s patients.
Led by Ruth Poliakine Baruchi, CEO, MyndYou optimizes the delivery of care for seniors living with mild and ongoing cognitive impairment via an artificial intelligence (AI) platform that aids clinicians in tracking and addressing cognitive-related disease, such as Dementia and Alzheimer’s.
The solution combines remote interaction with a monitoring app, analytic evaluation, and artificial intelligence (AI) analysis to individualize care based on definitive and objective data.